Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer.

Autor: Pala L; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy; Humanitas University, Milan, Italy., De Pas T; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Cocorocchio E; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Catania C; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Ceresoli G; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Laszlo D; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Zattarin E; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Rossi G; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy., Conforti F; Medical Oncology Unit, Humanitas Gavazzeni, Bergamo Italy; University of Milan, Milano, Italy. Electronic address: fabio.conforti1984@gmail.com.

Publikováno v: Seminars in oncology [Semin Oncol] 2024 Oct 28. Date of Electronic Publication: 2024 Oct 28.

"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer."

Autor: Pala L; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Sala I; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Pagan E; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., De Pas T; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Zattarin E; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Catania C; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Cocorocchio E; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Rossi G; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Laszlo D; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Ceresoli G; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Canzian J; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Valenzi E; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy., Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Conforti F; Department of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. Electronic address: fabio.conforti@gavazzeni.it.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2024 Feb; Vol. 73, pp. 103672. Date of Electronic Publication: 2024 Jan 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

Autor: Paccagnella, Adriano, Favaretto, A., Oniga, F., Barbieri, F., Ceresoli, G., Torri, W., Villa, E., Verusio, C., Cetto, G.L., Santo, A., De Pangher, V., Artioli, F., Cacciani, G.C., Parodi, G., Soresi, F., Ghi, M.G., Morabito, A., Biason, R., Giusto, M., Mosconi, P., Chiarion Sileni, V.

Publikováno v: In Lung Cancer 2004 43(1):83-91